CRD-750-202
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Effectiveness of CRD-750 in Subjects with Chronic Heart Failure with Preserved Ejection Fraction
- Stadium
- followup
- Middel
- Tovinontrine
- Populatie
- Hartfalen
- Fase
- II
- First Patient In
- 1 oktober 2024
- Last Patient In
- 23 mei 2025
- Last Patient Last Visit
- 1 december 2025
National Lead
prof. dr. A. Voors
Cardioloog
Studiedirecteur
